Debra BorchardtAugust 23, 2023
Despite an overall lack of liquidity, institutional investors - and the FDA - seem more comfortable with psychedelics.
FDA Archives - Green Market Report
Debra BorchardtAugust 23, 2023
Adam JacksonAugust 8, 2023
The FDA gave the nod to the University of Washington and UCLA.
Adam JacksonAugust 4, 2023
Net losses for the company rose due to R&D costs.
Adam JacksonJuly 18, 2023
The company's also cutting costs and streamlining where it can to grab more margin.
Adam JacksonJuly 5, 2023
This is not the first time the FTC and FDA have addressed the hemp-derivatives market.
Adam JacksonJune 27, 2023
Public comment on the draft proposal will be collected for the next 60 days.
John SchroyerJune 6, 2023
The group wants a voice at the table as the decision is being made.
Adam JacksonMay 19, 2023
The DEA indicated it could revisit the matter if the Ninth Circuit Court remanded the case.
Adam JacksonMay 4, 2023
The legality and safety of Delta 8 THC remains uncertain, yet it continues to attract entrepreneurs and investors.
Debra BorchardtMay 2, 2023
KETARX is an injectable ketamine formulation to treat a symptom of Parkinson's.
Get the latest cannabis news delivered right to your inbox
Unpack the industry with the daily cannabis newsletter for business leaders.